A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
Launched by FIRST HOSPITAL OF CHINA MEDICAL UNIVERSITY · Aug 18, 2025
Trial Information
Current as of August 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well artificial intelligence (AI) can help doctors analyze heart ultrasound images, called echocardiograms. The goal is to see if AI can accurately and quickly measure important heart details—like the size and function of heart chambers—compared to measurements done by doctors. The study also wants to find out if AI can work well in complicated heart conditions, such as valve problems or heart muscle diseases, and if using AI can make the testing process faster and more consistent across different hospitals.
Adults between 18 and 80 years old who have one of several heart conditions—including normal heart health, coronary artery disease, valve disease, high blood pressure affecting the heart, irregular heartbeat, heart failure, or certain types of heart muscle disease—may be able to join. People with poor-quality ultrasound images or congenital heart defects are not eligible. Participants can expect to have their echocardiograms reviewed by both doctors and the AI system to compare results. This study is currently recruiting patients and aims to improve how heart health is checked using new technology, potentially making diagnosis faster and more reliable for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥18 - 80 years;
- 2. Types of diseases (8 in total, 200 cases each):
- • 1. Normal heart
- • 2. Coronary heart disease (with segmental thinning and abnormal movement)
- • 3. Valve disease (valve stenosis or reflux)
- • 4. Hypertensive heart disease
- • 5. Atrial fibrillation
- • 6. Heart failure
- • 7. Dilated cardiomyopathy
- • 8. Hypertrophic cardiomyopathy
- Exclusion Criteria:
- • 1. Patients with congenital heart disease
- • 2. Patients with poor image quality
About First Hospital Of China Medical University
The First Hospital of China Medical University is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to facilitate the development of new treatments and therapies. Committed to ethical practices and patient safety, the hospital collaborates with a network of researchers and healthcare professionals to ensure rigorous study design and implementation. Its mission is to contribute to the global body of medical knowledge while enhancing the quality of life for patients in China and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Shanghai, , China
Shenyang, Liaoning, China
Shenyang, Liaoning, China
Chongqing, , China
Shantou, Guangdong, China
Fushun, Liaoning, China
Xi'an, Shanxi, China
Baise, Guangxi, China
Chaoyang, Liaoning, China
Wuhan, Hubei, China
Haikou, Hainan, China
Anshan, Liaoning, China
Chongqing, , China
Yulin, Guangxi, China
Meizhou, Guangdong, China
Fuzhou, Fujian, China
Chongqing, , China
Shangrao, Jiangxi, China
Shijiazhuang, Hebei, China
Linfen, Shanxi, China
Huainan, Anhui, China
Zunyi, Guizhou, China
Shenzhen, Guangdong, China
Guilin, Guangxi, China
Liuzhou, Guangxi, China
Loudi, Hunan, China
Zhuzhou, Hunan, China
Baotou, Inner Mongolia, China
Shangrao, Jiangxi, China
Xining, Qinghai, China
Tai'an, Shandong, China
Jiangyou, Sichuan, China
Chongqing, , China
Chongqing, , China
Chongqing, , China
Chongqing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported